• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保健差距与患者个体因素对周围动脉疾病临床结局的影响。

The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease.

机构信息

Division of Cardiology, Duke University Health System, Durham, NC.

Department of Population Health Sciences, Duke University, Durham, NC.

出版信息

Am Heart J. 2021 Sep;239:135-146. doi: 10.1016/j.ahj.2021.05.014. Epub 2021 May 27.

DOI:10.1016/j.ahj.2021.05.014
PMID:34052213
Abstract

BACKGROUND

PAD increases the risk of cardiovascular mortality and limb loss, and disparities in treatment and outcomes have been described. However, the association of patient-specific characteristics with variation in outcomes is less well known.

METHODS

Patients with PAD from Duke University Health System (DUHS) between January 1, 2015 and March 31, 2016 were identified. PAD status was confirmed through ground truth adjudication and predictive modeling using diagnosis codes, procedure codes, and other administrative data. Symptom severity, lower extremity imaging, and ankle-brachial index (ABI) were manually abstracted from the electronic health record (EHR). Data was linked to Centers for Medicare and Medicaid Services data to provide longitudinal follow up. Primary outcome was major adverse vascular events (MAVE), a composite of all-cause mortality, myocardial infarction (MI), stroke, lower extremity revascularization and amputation.

RESULTS

Of 1,768 patients with PAD, 31.6% were asymptomatic, 41.2% had intermittent claudication (IC), and 27.3% had chronic limb-threatening ischemia (CLTI). At 1 year, patients with CLTI had higher rates of MAVE compared with asymptomatic or IC patients. CLTI and Medicaid dual eligibility were independent predictors of mortality. CLTI and Black race were associated with amputation.

CONCLUSIONS

Rates of MAVE were highest in patients with CLTI, but patients with IC or asymptomatic disease also had high rates of adverse events. Black and Medicaid dual-eligible patients were disproportionately present in the CLTI subgroup and were at higher risk of amputation and mortality, respectively. Future studies must focus on early identification of high-risk patient groups to improve outcomes in patients with PAD.

摘要

背景

PAD 增加了心血管死亡率和肢体丧失的风险,并且已经描述了治疗和结果的差异。然而,患者特定特征与结果变化的关联知之甚少。

方法

从杜克大学健康系统(DUHS)确定了 2015 年 1 月 1 日至 2016 年 3 月 31 日期间患有 PAD 的患者。通过使用诊断代码、程序代码和其他行政数据进行地面真实裁决和预测建模来确认 PAD 状态。症状严重程度、下肢影像和踝肱指数(ABI)从电子健康记录(EHR)中手动提取。数据与医疗保险和医疗补助服务中心(CMS)数据链接,以提供纵向随访。主要结果是主要血管不良事件(MAVE),这是全因死亡率、心肌梗死(MI)、中风、下肢血运重建和截肢的综合指标。

结果

在 1768 名患有 PAD 的患者中,31.6%的患者无症状,41.2%的患者间歇性跛行(IC),27.3%的患者患有慢性肢体威胁性缺血(CLTI)。在 1 年时,CLTI 患者的 MAVE 发生率高于无症状或 IC 患者。CLTI 和医疗补助双重资格是死亡率的独立预测因素。CLTI 和黑人种族与截肢有关。

结论

CLTI 患者的 MAVE 发生率最高,但患有 IC 或无症状疾病的患者也有很高的不良事件发生率。黑人患者和同时符合医疗补助条件的患者不成比例地出现在 CLTI 亚组中,分别面临更高的截肢和死亡率风险。未来的研究必须集中于早期识别高危患者群体,以改善 PAD 患者的预后。

相似文献

1
The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease.医疗保健差距与患者个体因素对周围动脉疾病临床结局的影响。
Am Heart J. 2021 Sep;239:135-146. doi: 10.1016/j.ahj.2021.05.014. Epub 2021 May 27.
2
Regional variation in racial disparities among patients with peripheral artery disease.外周血管疾病患者中种族差异的地域差异。
J Vasc Surg. 2018 Aug;68(2):519-526. doi: 10.1016/j.jvs.2017.10.090. Epub 2018 Feb 16.
3
Association of Ankle-Brachial Indices With Limb Revascularization or Amputation in Patients With Peripheral Artery Disease.踝臂指数与外周动脉疾病患者肢体血运重建或截肢的相关性。
JAMA Netw Open. 2018 Dec 7;1(8):e185547. doi: 10.1001/jamanetworkopen.2018.5547.
4
Impact of risk factor control on peripheral artery disease outcomes and health disparities.危险因素控制对周围动脉疾病结局和健康差异的影响。
Vasc Med. 2022 Aug;27(4):323-332. doi: 10.1177/1358863X221084360. Epub 2022 Apr 7.
5
Competing risk analysis to estimate amputation incidence and risk in lower-extremity peripheral artery disease.竞争风险分析估计下肢外周动脉疾病的截肢发病率和风险。
Vasc Med. 2024 Oct;29(5):496-506. doi: 10.1177/1358863X241268727. Epub 2024 Sep 1.
6
Racial disparities in the use of revascularization before leg amputation in Medicare patients.医疗保险患者在截肢前进行血运重建治疗的种族差异。
J Vasc Surg. 2011 Aug;54(2):420-6, 426.e1. doi: 10.1016/j.jvs.2011.02.035. Epub 2011 May 14.
7
Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates.间歇性跛行患者的血运重建会导致更多的慢性肢体威胁性缺血和更高的截肢率。
J Vasc Surg. 2021 Sep;74(3):771-779. doi: 10.1016/j.jvs.2021.02.045. Epub 2021 Mar 26.
8
Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization.解剖学流出道评分可预测接受血运重建的下肢外周动脉疾病患者的心血管结局。
Am Heart J. 2015 Aug;170(2):400-8. doi: 10.1016/j.ahj.2015.04.026. Epub 2015 May 2.
9
Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.外周动脉疾病血管内治疗结局的种族差异:对加利福尼亚州医院的评估,2005 - 2009年
Ann Vasc Surg. 2015 Jul;29(5):950-9. doi: 10.1016/j.avsg.2015.01.006. Epub 2015 Mar 7.
10
Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age.高龄患者下肢慢性肢体威胁性缺血的血运重建。
Ann Vasc Surg. 2021 Apr;72:517-528. doi: 10.1016/j.avsg.2020.08.135. Epub 2020 Sep 12.

引用本文的文献

1
Impact of open femoral endarterectomy on treating multilevel iliac and common femoral artery occlusive disease.开放式股动脉内膜切除术治疗多节段髂动脉和股总动脉闭塞性疾病的疗效
Front Surg. 2025 Jan 21;12:1445846. doi: 10.3389/fsurg.2025.1445846. eCollection 2025.
2
Thromboembolic Events in the Hemodialysis Setting: Understanding Risk Profiles and Cumulative Incidences to Inform Clinical Trial Design.血液透析环境中的血栓栓塞事件:了解风险概况和累积发病率以指导临床试验设计。
J Am Heart Assoc. 2025 Jan 7;14(1):e033983. doi: 10.1161/JAHA.124.033983. Epub 2024 Dec 24.
3
Regional variation in the use of revascularisation for peripheral artery disease in Japan: a cross-sectional observational study.
日本外周动脉疾病血运重建治疗应用的区域性差异:一项横断面观察性研究。
BMJ Open. 2023 Nov 21;13(11):e076399. doi: 10.1136/bmjopen-2023-076399.
4
Vascular surgeons are positioned to fight healthcare disparities.血管外科医生正处于应对医疗保健差异的有利位置。
J Vasc Surg Venous Lymphat Disord. 2024 Jan;12(1):101674. doi: 10.1016/j.jvsv.2023.08.013. Epub 2023 Sep 11.
5
Disparities in peripheral artery disease care: A review and call for action.外周动脉疾病护理中的差异:综述与行动呼吁。
Semin Vasc Surg. 2022 Jun;35(2):141-154. doi: 10.1053/j.semvascsurg.2022.05.003. Epub 2022 May 8.
6
Impact of risk factor control on peripheral artery disease outcomes and health disparities.危险因素控制对周围动脉疾病结局和健康差异的影响。
Vasc Med. 2022 Aug;27(4):323-332. doi: 10.1177/1358863X221084360. Epub 2022 Apr 7.
7
Update on the pathophysiology and medical treatment of peripheral artery disease.外周动脉疾病的病理生理学和医学治疗进展。
Nat Rev Cardiol. 2022 Jul;19(7):456-474. doi: 10.1038/s41569-021-00663-9. Epub 2022 Jan 7.